Compare ABVX & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABVX | TTEK |
|---|---|---|
| Founded | 2013 | 1966 |
| Country | France | United States |
| Employees | N/A | N/A |
| Industry | | Military/Government/Technical |
| Sector | | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.0B |
| IPO Year | N/A | 1991 |
| Metric | ABVX | TTEK |
|---|---|---|
| Price | $114.15 | $35.45 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 5 |
| Target Price | ★ $118.33 | $43.25 |
| AVG Volume (30 Days) | ★ 1.9M | 1.8M |
| Earning Date | 08-11-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 0.77% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.93 |
| Revenue | $6,231,374.00 | ★ $4,617,360,000.00 |
| Revenue This Year | $6.80 | N/A |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | ★ N/A | $36.32 |
| Revenue Growth | N/A | ★ 6.84 |
| 52 Week Low | $4.77 | $27.27 |
| 52 Week High | $148.83 | $42.98 |
| Indicator | ABVX | TTEK |
|---|---|---|
| Relative Strength Index (RSI) | 43.25 | 58.66 |
| Support Level | $116.20 | $33.73 |
| Resistance Level | $129.56 | $35.30 |
| Average True Range (ATR) | 7.87 | 0.81 |
| MACD | -2.47 | 0.06 |
| Stochastic Oscillator | 15.05 | 70.98 |
Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Company is evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two common forms are UC and CD.
Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.